EGRX insider transaction filings
EAGLE PHARMACEUTICALS, INC. — 8 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-03-01. Screen EGRX transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for EGRX between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — EAGLE PHARMACEUTICALS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-03-01 | 4 | Tarriff Scott — 10% owner | Tax withholding (F): 2,119 @ $6.27 | EDGAR |
| 2024-02-29 | 4 | Cahill Brian Joseph — CHIEF FINANCIAL OFFICER | Grant/award (A): 3,800 @ $0 · Tax withholding (F): 1,589 @ $6.44 | EDGAR |
| 2024-02-29 | 4 | Tarriff Scott — 10% owner | Grant/award (A): 12,950 · Tax withholding (F): 3,154 @ $6.44 | EDGAR |
| 2024-02-06 | 4 | Cahill Brian Joseph — CHIEF FINANCIAL OFFICER | Tax withholding (F): 934 @ $5.85 | EDGAR |
| 2024-01-09 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 735 @ $5.13 | EDGAR |
| 2024-01-09 | 4 | Tarriff Scott — 10% owner | Tax withholding (F): 4,322 @ $5.13 | EDGAR |
| 2023-12-22 | 4 | Graves Michael — Interim Executive Chair & PEO, Director | Grant/award (A): 293,000 (derivative) @ $0 | EDGAR |
| 2023-12-20 | 4 | Cahill Brian Joseph — Chief Financial Officer | Tax withholding (F): 452 @ $4.76 | EDGAR |
Recent 8-K events — EAGLE PHARMACEUTICALS, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-12-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.03 — Material Modification to Rights of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-27 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-15 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-11-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-10-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-10-02 | 8-K | 2.02 — Results of Operations and Financial Condition 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 4.02 — Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review 8.01 — Other Events | EDGAR |
| 2024-08-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-08-05 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-07-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2024-05-29 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=EGRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →